Clinical application of IL6 in cancer therapy
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in Research in Immunology
- Vol. 143 (7) , 777-783
- https://doi.org/10.1016/0923-2494(92)80023-e
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Interleukin-6 and renal cell cancer: Production, regulation, and growth effectsCancer Immunology, Immunotherapy, 1992
- Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.The Journal of Experimental Medicine, 1991
- The in vivo Anti‐tumor Effect of Human Recombinant Interleukin‐6Japanese Journal of Cancer Research, 1990
- Antitumor activity of recombinant interleukin 6 in mice.The Journal of Experimental Medicine, 1990
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989
- The biology of interleukin-6Blood, 1989
- Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma.The Journal of Experimental Medicine, 1989
- IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.The Journal of Immunology, 1989